However, it is difficult to extrapolate these results to the in vivo setting since EGFR might respond not only to EGF but also to TGF-α, AR, EPGN, BTC, HB-EGF and EREG, which are also increased in tumor tissues (9–15). This evidence concerns the gene EPGN and neoplasm.